Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Carcinogenesis|July 1, 2020
Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancerShanshan Deng, Marco Ramos-Castaneda, Walter V Velasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2021
Genomic Profiling of Lung Adenocarcinoma in Never-SmokersSiddhartha Devarakonda, Yize Li, Fernanda Martins Rodrigues, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 23, 2012
Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profilingHumam Kadara, Li Shen, Junya Fujimoto, et al.
Cancer Immunology Research|May 17, 2018
IL22 Promotes <i>Kras</i>-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness PropertiesNasim Khosravi, Mauricio S Caetano, Amber M Cumpian, et al.
Cancer|October 21, 2017
Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinomaFrederico O Gleber-Netto, Mei Zhao, Sanchit Trivedi, et al.
Nature Communications|November 4, 2018
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancerMauricio S Caetano, Maya Hassane, Hieu T Van, et al.
Nature Communications|July 26, 2022
Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancerCaterina Bartolacci, Cristina Andreani, Gonçalo Vale, et al.
JCI Insight|August 10, 2018
Requirement for MUC5AC in KRAS-dependent lung carcinogenesisAlison K Bauer, Misha Umer, Vanessa L Richardson, et al.
International Journal of Molecular Sciences|August 26, 2022
A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune ResponseEhsan Irajizad, Johannes F Fahrmann, James P Long, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLCPedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca, et al.
Pageof 14